Dp Dermaceuticals

Dp Dermaceuticals is an Australian professional skincare brand created by DermapenWorld, the Sydney company behind the Dermapen microneedling device. The range was built as a companion to that device — a line of medical-grade products meant to be applied before, during and after a needling treatment rather than sold as everyday skincare. The "dp" in the name refers to Dermapen, and the brand presents itself as the world's first meso-infusion skincare range designed specifically for microneedling [1].

The brand is distributed to clinics and authorised treatment providers internationally; in North America it trades through a distributor based in Miami, Florida, while the company itself is Australian. It remains active, with current product launches and live retail and social channels.

DermapenWorld was founded by Stene Marshall, who is based in Sydney and serves as the company's chief executive [4]. According to the company, Marshall founded DermapenWorld in 2010 and developed the first automated Dermapen microneedling device [4]. Its parent entity, Equipmed, was established in Australia in 1976.

The skincare line itself came afterward. DermapenWorld describes Dp Dermaceuticals as a separate creation built around the needling device, with the first product launched in 2011 [4]. This produces a small distinction in dates: 2010 marks the founding of DermapenWorld and its device, while 2011 is the year the Dp Dermaceuticals skincare range began. The 2011 launch is the relevant starting point for the skincare brand, with 2010 belonging to the parent company and its hardware [4].

Dp Dermaceuticals is owned by DermapenWorld, whose own parent company is the Australian firm Equipmed [4]. The North American distributor operating the dpderm.com storefront is a sales channel based in Miami, not the brand's origin or owner; the company describing and creating the line is the Sydney-based DermapenWorld.

The brand's central idea is what DermapenWorld calls the "Power of Synergy" — the notion that microneedling works best when the device, the practitioner training, the skin science and the products are treated as one system rather than separate purchases [4]. Within that framing, Dp Dermaceuticals is positioned as the protocol products developed specifically for use during needling, formulated, the company says, in consultation with dermatologists, doctors and aestheticians.

This is a professional, practitioner-facing brand rather than a consumer one. Its products are sold through clinics and authorised treatment providers, and the company states it reaches almost 70 countries with providers in more than 60. The brand sums up its line as the "non-negotiables for microneedling," and frames its mission as enabling each practitioner to deliver the best possible treatment outcomes through protocol-based products.

The range spans cleansers, serums, correctors, moisturisers, eye products, sun protection and masks, alongside professional offerings such as the ÜBER Peels and the Meso-Glide MG Collection used during treatments. More recent additions include exosome-based products — the EXO-SKIN serum and the EXO-GROW hair line — flagged as new launches on the brand's storefront.

Several proprietary technologies sit at the centre of the products. The best-known is the HylaFuse Complex, which the company describes as a patented system combining three different molecular weights of hyaluronic acid intended to work together [3]. The smallest molecule, at a manipulated 10 kilodaltons, is described as carrying additional active ingredients such as vitamin C, copper peptides, zinc and B5 into deeper layers of the skin, while larger weights are positioned for surface hydration and barrier support. The company says the complex has been bioengineered to pass through the skin's barriers and plump the skin from within [3]. Other named technologies include Calphasomes and GGP, described as a telomere innovation.

The brand cites an independent study from Monash University in Melbourne as support for the behaviour of hyaluronic acid at the 10-kilodalton weight [3]. The accompanying Dermapen 4 device, marketed alongside the skincare, is described as FDA-cleared for the treatment of facial acne scars and as creating micro-channels markedly faster than comparable devices [2].

Design recognition for the company has centred on its hardware. The Dermapen 4 device won an Australian Good Design Award in the Medical and Scientific category in 2018, presented at a ceremony at the Sydney Opera House [5]. The following year it was named a winner in the German Design Award's Medical, Rehabilitation and Health Care category [5]. These awards attach to the device rather than to the skincare line specifically, but both originate from the same company.

Dp Dermaceuticals is an active, currently trading brand. Its North American storefront is in operation with recently launched exosome ranges marked as new, and its social channels remain active. The wider DermapenWorld network continues to distribute internationally across roughly 70 countries.